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Summary
Membrane cofactor protein (MCP) is a complement regulatory protein that is expressed on human
cells and cell lines as two relatively broad species with M, of 58,000-68,000 and 48,000-56,000.
The structure of a previously reported cDNA clone indicated that MCP was a type 1 membrane
glycoprotein and a member of the regulators of complement activation gene/protein cluster.
However, it did not provide an explanation for the unusual phenotypic pattern ofMCP. Therefore,
in parallel with an analysis of the gene, additional cDNAs were cloned and characterized. Six
different MCP cDNA classes were identified. All encode the same 5' untranslated signal peptide,
four SCRs, transmembrane domain, and basic amino acid anchor. However, they differ in the
length and composition of an extracellular serine/threonine/proline (STP)-rich area, a site of
heavy O-glycosylation, and cytoplasmic tail. Analysis of the MCP gene demonstrated that the
variation in cDNA structure was a result of alternative splicing. Peripheral blood cells and cell
linespredominantly expressed four of the six isoforms. These varied by the presence or absence
of an STP-rich segment of 15 amino acids (STPB) and by the use of one of two cytoplasmic
domains. Analysis by polymerase chain reaction, Northern blots, and transfection indicated that
the predominance of MCP cDNA isoforms with STPB correlated with the high molecular
weight protein phenotype, while the predominance of isoforms without STPB correlated with
the lower molecular weight phenotype. The expression in a single cell of four distinct protein
species with variable STP-rich regions and cytoplasmic tails represents an interesting example
of the use of alternative splicing to provide variability in a mammalian protein.
M
embrane cofactor protein (MCP; t CD46) is a widely
distributed regulatory protein of the complement
system that binds to the complementactivation products C3b
and C4b and serves as a cofactor for their proteolytic inacti-
vation by factor I (1-3). Except for erythrocytes, MCP has
been found on nearly every cell and tissue examined: cells
of epithelial, endothelial, and fibroblast lineages (4, 5), PBL
(6-8), platelets (5, 7, 9), sperm (10), trophoblast tissues (11-13),
and in serum, saliva, and seminal fluid (5). Because of this
tissue distribution and functional profile, it has been postu-
lated that MCP helps prevent complement activation on host
cells (reviewed in references 14 and 15). Recently, this hy-
t Abbreviations used in this paper: MCP, membrane cofactor protein; nt,
nucleotide; RCA, regulators of complement activation; SCR, short
consensus repeat; STP, serine/threonine/proline.
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pothesis has been confirmed through two separate demon-
strations that MCP can protect cells from complement-
mediated lysis (16, 17).
MCP migrates on SDS-PAGE as a broad doublet with Mr
of the two species of 58,000-68,000 and 48,000-56,000 (6,
18). Although the larger protein form contains more sialic
acid (18,19) and, therefore, presumablymore O-linked sugars,
the two species are similar functionally, structurally, and an-
tigenically. The relative quantity expressed ofeach MCP species
is inherited in an autosomal codominant fashion (20, 21) .
One MCP cDNA has been isolated and characterized (22).
Beginning at its NHZ terminus (see Fig. 1), MCP is com-
posed of four of the -60 amino acid, cysteine-rich repeating
motifs known as short consensus repeats (SCRs). Such units
are the building blocks of the regulators of complement acti-
vation (RCA) protein/gene cluster found at 1832 (reviewed
J. Exp. Med. C The Rockefeller University Press " 0022-1007/91/07/0093/10 $2.00
Volume 174 July 1991 93-102in references 1 and 23), at which the structural gene forMCP
also maps (24-26). Immediately 3' of the SCRs is a serine/
threonine/proline (STP)-rich region, a likely area for exten-
sive O-glycosylation. This is followed by a short segment
of unknown significance, a transmembrane domain, basic
amino acid anchor, and a cytoplasmic tail.
We nowreport sixadditional cDNA clones, each encoding
a distinct protein class of MCP. Using PCR of mRNA,
Northern blots, andtransfections ofcDNAs, we demonstrate
that four of these isoforms are predominantly expressed by
peripheral bloodcellsand cell lines. Throughthecloningand
characterization of the MCP gene, we show that alternative
splicing produces these distinct classes of MCP and that the
presence or absenceof an STP-rich exon determines thepro-
tein phenotype.
Materials and Methods
Construction and Screening ofcDNA and Genomic Libraries.
￿
A
cDNA librarywas prepared from 10 p.g of HeLa poly(A)' RNA
(Clontech, Palo Alto, CA). cDNA inserts were size selected to be
>3 kb by agarose gelelectrophoresis, ligated into A Zap' 11, pack-
aged in Gigapack' Gold, and plated on XLl-Blue Escherichia coli
(all from Stratagene, La Jolla, CA). This library was probed with
MCP-1 cDNA (22),whichwaslabeled by random hexanucleotide
priming (27).
Twohuman genomicbacteriophagelibraries, obtained from the
American Type Culture Collection (ATCC; Rockville, MD) and
Stratagene, were constructed by partial EcoRl or Sau3A1 diges-
tion ofhuman genomicDNA, followed by insertion into thevectors
Charon 4A and XDASH, respectively. They were screened by
standard techniques (27) with MCP cDNA or MCP genomic
DNA labeled by random hexanucleotide priming. Achromosome
1-specific library (from ATCC) was also screened with a 3' UT
specific oligonucleotide labeled at its 5' endby T4 kinase. This li-
brary was constructed by complete EcoRl digestion followed by
insertion into the vector Charon 21A.
DNA Isolation and Subdoning.
￿
Positive clones from the Zap'
II HeLa library were plaque purified followed by in vivo excision
ofthe phagemid permanufacturer's protocol (Stratagene). Positive
clones from the genomic librarywere plaque purified, andDNA
wasisolated using asmall-scale bacteriophage preparation (28). Bac-
teriophage insert DNAwassubclonedinto theEcoRl site ofpUC
19 by standard techniques (27).
RNA Isolation.
￿
Total RNAwasisolated from cell lines or pe-
ripheral blood cells by either the guanidium isothiocyanate/CsCl
(29) or acid phenol (30) methods. PBMC were isolated using stan-
dard Ficoll-Hypaque separation methods(6, 31). Isolated RNAwas
quantitated by either opticaldensity or ethidium bromide staining
of agarose gels (27). Previously studied human cell lines used in
this investigation were U-937 (monocyte/macrophage), K-562
(erythroleukemia), HSB-2(T lymphocyte), Hela (carcinoma ofthe
cervix), and HEp-2 (carcinoma of the larynx) (4, 6).
cDNA Synthesis and PCR ofFulllength cDNA.
￿
20 pg of total
RNA, obtained from K-562andHEp-2cell lines, as describedabove,
wasused for each first-strand synthesisreaction. RNAwasincubated
at 65°C for3minandthen quick-chilled at 4°C. First-strand cDNA
synthesis wasthen performedusing theCopy Kit(Invitrogen, San
Diego, CA); however, a3' UT MCP-specific antisense primer was
used in place of oligo(dT) or random primers. This primer was
AAGCCACATTGCAATATTAGCTAAGCCACAGT First strand
cDNA was then ethanol precipitated and the product was used
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for each subsequent PCR. Except for primers, reagents used for
the PCRwere from the GeneAmp' kit(Perkin ElmerCetus, Nor-
walk, CT). TheMCP-specific primers were as follows: the5' primer
possessed an EcoRl site added to the 5' UT MCP sequence of
ATTGTTGCGTCCCATATCTGGACCCAGAAGGG; the anti-
sense MCPprimer was thesame as used forfirst-strand synthesis,
except an EcoR1 restriction site was added. Cyclingconditions were
an initial denaturation of 94°C for 5 min followed by 39 cycles
consisting of a denaturation temperature of 94°C for 1 min, an
annealing temperature of 55"C for 1 min, and an extension tem-
perature of72°Cfor2min. At thecompletion of thecycling reac-
tions, a final extension was performed for 10 min at 72°C.
The PCR products were ethanol precipitated, digested with
EcoRl, and gelisolated. Theproductwas then subclonedinto the
EcoRl site of pUC 19. Distinct clones were sequenced in their
entirety.
DNA Sequence Determination and Mapping.
￿
Double-stranded
DNAsequencing wasperformedusingthe Sequenase Kit (United
States Biochemical Corp., Cleveland, OH). Sequencing primers in-
cluded forward andreverse M13primersand synthesized oligonu-
cleotides corresponding to known regions ofMCPcDNA andMCP
intron-specific sequences. Bacteriophage inserts ofgenomicclones
were aligned by restriction mapping, hybridization to MCP exon-
and intron-specific probes, and sequencing.
Northern Blots. Total RNA was isolated (as above). RNA
samples, alongwith RNAmarkers(0.24-9.5 kb;Bethesda Research
Laboratories, Gaithersburg, MD) were run on a 1% agarose gel
by standard methods(27), except that theconcentrationof formal-
dehyde in the gelwas decreasedto 0.22 M. Gels were blotted onto
Nitroplus 2000 membrane (MicronSeparations, Inc., Westborough,
MA). Blots were hybridized and washed at high stringency (27).
cDNA Synthesis and PCR for "Short Form"ofcDNA .
￿
2 Ag of
U-937, 10 ug of K-562, 12 ttg of HSB-2, 9 pg of HeLa, 0.2 p.g
of HEp-2 total RNA, and 5-20 Itg of six individuals' peripheral
bloodcellstotalRNA were used for each first-strand synthesisreac-
tion in a total volume of 20 pi (Copy Kit; Invitrogen). Reagent
concentrations were as permanufacturer's protocol, except that both
oligo(dT) and random primers were used. Two first-strand con-
trols were used. One was the same amount of cell line RNA and
all reaction reagents but without reverse transcriptase. The other
was 20 hg of yeast tRNA with all first-strand reaction reagents
includingreversetranscriptase.First-strand reaction mixtures were
incubated for 2 h at 42°C and then at 72'C for 10 min before
being ethanol precipitated and resuspended in 30 pl of water.
PCR amplification was performed as described earlier using
GeneAmp' Kit, except that cycling numbers were varied to pro-
vide linearityof the reaction. Thesequence of the 5' MCP-specific
primer wasTGTCGACTGGAATTCCTGGTCAAATGTCGATT
TCCAGTAGTCGAAAAT, andofthe3' primer was GATATTCA-
CCTGCAGGAAGCCACATTGCAATATTAGCTAAGCCACAGT
ThePCRproduct wasanalyzed on a3% agarose gel. PCRexperi-
ments using plasmids containing known MCP cDNAswere per-
formed as above. The PCR products from cell lines and plasmids
were analyzed by digestion with either Sall or Stul.
Transfection ofMCP Isoforms.
￿
The cDNA isoforms were sub-
cloned into theEcoRl site oftheexpression vector SFFVneo (32).
PlasmidDNAwas subsequently prepared using thepZ523kitfrom
5 Prime3 Prime, Inc. (WestChester, PA). ChineseHamsterOvary
cells (CHO-K1; ATCC), were then transfected with the prepared
DNA using Lipofectin' Reagent (Bethesda Research Laborato-
ries) following the manufacturer's suggestion for preparation of
stable transfectants. CHO cells were grown in Ham's F-12 with
10% FCS, penicillin (100 U/ml), and streptomycin (100 ug/ml).2 d aftertransfection, cells were grown in the same medium sup-
plemented with Geneticin® (0.5 mg/ml activity concentration)
(Gibco Laboratories, Grand Island, NY). Transfected cells were
sorted on an EPIC 753 (Coulter Corp., Hialeah, FL) one to four
times depending on expression levels.
Labeling andImmunoprecipitationofCells.
￿
Unless otherwise in-
dicated, reagents were obtained from SigmaChemical Co. (St. Louis,
MO). Cell lines and stably transfected cells, the latter grown to
70-80% confluency, were washed and "starved" for 1 h at 37°C
in cysteine-free medium containing 10% dialyzed FCS. After this,
"S-cysteine was added (100 uCi/ml) (1,000 Ci/mmol; New En-
gland Nuclear, Boston, MA), and the incubation continued for
4 h. PBMC were surface labeled with ~..I (6).
To immunoprecipitate MCP, cells were solubilized in lysis buffer
(1% NP-40 in 10 mM TRIS, pH 7.4, 150 mM NaCl, 0.05% SDS,
2 mM PMSF, and 2.5 mM EDTA). After incubating at 4°C for
20 min, cell debris was pelleted at 10,000g for 10 min. Cell lysate
supernatants were "pre-cleared" for 30 min at 4°C by adding 5
Al normal rabbit serum, 10 ill (10 Ag) UPC-10 (a mouse mono-
clonal IgG2a of unknown specificity), and 50 p,l packed protein
A-agarose (Boehringer Mannheim Biochemicals, Indianapolis, IN).
The "cleared" supernatant was then incubated for 1 h at 4°C with
5 pl of ascites fluid containingE4.3, an IgG2amAb to MCP (33-35).
Subsequently, 15 Ell ofprotein A-agarose was incubated for 20 min.
After washing the pelleted sample with cell lysis buffer containing
0.5 M NaCl, gel buffer was added and the sample heated to 100°C
for 3 min. Gel buffer contained 10% (vol/vol) glycerol, 0.2% SDS,
62 mM TRIS-HCI (pH 6.8). The supernatant was fractionated
on a 10% SDS polyacrylamide gel using the Laemmli system (36).
Gels were fixed, stained, treated with Amplify (Amersham Corp.,
Arlington Heights, IL), dried, and exposed to Kodak XAR film.
Results
Multiple MCP cDNAs.
￿
The initial MCP cDNA clone
(MCP-9) did not provide an explanation for the two bands
on SDS-PAGE and was nearly 2 kb smaller than the major
transcript (22). Therefore, additional MCP cDNA clones were
sought by screening a cDNA library and by PCR. Since HeLa
cells express a relatively large quantity of both MCP species
(4), a size-selected (>3.0 kb) cDNA library was prepared and
two informative clones were characterized. Clone HL-1 pos-
sessed sequence identical to MCP-9 (22) and therefore en-
coded for the same protein. However, HL-1 added 102 nucleo-
tides (nt) of 5' UT sequence and 1,580 nt of 3' UT sequence
for a total length of 3,212 nt (All clone sequences have been
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Figure 1.
￿
A schematic diagram ofMCP cDNA. Data are derived from
a previouslyreported cDNA clone, MCP-1(22). Coding regions are shown
by boxes, and 5' and 3' UT regions by lines. The protein consists of 384
amino acids and, beginning at its NH2 terminus, has the following struc-
ture: signal peptide, 34 amino acids; consensus repeats 1-4, 251 amino
acids; STP-rich region, 29 amino acids; unknown region, 13 amino acids;
Transmembrane domain and cytoplasmic anchor, 34 amino acids, cytoplasmic
tail 23 amino acids.
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A,
submitted to the GenBank~`/EMBL Data Bank). A Northern
blot, using totalRNA from K-562, U-937, HeLa, and HEp-2
cell lines, was hybridized at high stringency with a 0.6-kb
EcoRl fragment unique to this additional 3' UT sequence.
The blot indicated that this sequence was transcribed and
was part of the major transcript of all four cell lines (data
not shown). Additionally, HIA possessed the more common
polyadenylation signal AATAAA, as opposed to the atypical
signal of MCP-9 (AATATA or AATGAA) (22).
Another clone from the HeLa Library (HL27) was iden-
tical to HL1, except for a 93-bp sequence located immedi-
ately after the transmembrane domain. Because ofan inframe
stop codon, this segment coded for an alternate cytoplasmic
tail of 16 amino acids followed by 45 nt of 3' UT sequence
(Fig. 2 A). The remaining 3' UT sequence in HL-27 was
identical to the cDNA sequence ofHL1. Thus, the sequence
for the cytoplasmic tail identified in the original MCP clone
(MCP-9) (22) became part of the 3' UT area in clone HL-27.
Due to the ordering of these segments, this alternate tail of
clone HL27 was designated CYTI, and the initially charac-
terized MCP cytoplasmic tail was designated CYT2. A
Northern blot, hybridized at high stringency with an an-
tisense oligonucleotide to this 93-bp insert, demonstrated that
all four of the cell linesexamined possessed transcripts bearing
this insert but that the quantity was variable (Fig. 2 B) .
PCR was also used to generate cDNAs. MCP-specific
primers from the 5' UT and 3' UT regions were used to pro-
duce clones that span the coding region of MCP. From both
K-562 and HEp-2 total RNA, these primers produced PCR
products of -1.4 kb. Subclones, sequenced in their entirety,
revealed four additional forms of MCP cDNA.
Clones K5-9 and K5-22, derived from cell line K-562, pos-
sessed an additional segment immediately after SCR-4 and
before the previously defined STP region of MCP. This seg-
ment was termed STP^ (Figs. 3 and 4) because, if translated,
.9 of 15 amino acids were S, T, or P. The cDNA bearing this
45-nt insert appeared with CYTI in clone K5-9 and with
CYT2 in clone K5-22 (Fig. 4) . A Northern blot, hybridized
with an antisense probe in STPA, gave a weak signal (data
not shown), suggesting that transcripts bearing this insert
represented rare species in the four cell lines examined (also,
see below) .
PCR of HEp-2 totalRNA yielded two other clones, H2-
14 and H2-15, in which a portion of the STP region, termed
STPB, was deleted. H2-14 and H2-15 were identical except
that H2-14 contained CYTI and H2-15 contained CYT2.
Fig. 4 summarizes the clones characterized. Of note, the ad-
dition of CYTI and STPA, or deletion of STPB, did not dis-
rupt the reading frame.
PCR Analysis ofthe Variable Regionswithin MCPmRNAs.
We next asked which of the six transcripts were commonly
expressed. To answer this, two primers spanning the area of
variability, from SCR-4 to the 3' UT region, were used in
the PCR.
The PCR products derived from the total RNA of the
cell lines were found to consist of variable quantities of four
bands (Fig. 5) . To identify these products, the same primers
were used to amplify this area from cloned full-length MCPGTGCTGCCTCCATCTAGTACAAAACCTCCAGCTTTGAGTCATTCA
V L P P S S T K P P A L S H S
Figure 3 .
￿
nt and derived amino acid sequence of STPA . This 45-nt in-
sert codes for 15 amino acids, of which nine are S, T, or P. The insert
is positioned immediately after SCR-4 and before the previously described
STP region (see Fig. 1) .
cDNAs bearing known isoforms (Fig . 6) . The resultant
product was compared with those obtained from the HeLa
cell line. The known PCR products of Fig . 6, lanes 1, 2,
5, and 6 align with the four bands from HeLa cells, and also
have the expected size for their respective mRNAs .
To further verify the identity of the four PCR products,
a restriction enzyme analysis was undertaken . A Salt site is
located in the sequence of STPB, and a Stul site is in STPB
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Figure 2 .
￿
Cytoplasmic tail one (CYT') . (A) nt and derived
amino acid sequence. The encoded amino acids are centered
under the second nt of each triplet codon . (B) Northern blot
probed with an antisense oligonucleotide to CYTI . Total
RNA from each of the four cell lines was probed with an
antisense oligonucleotide to CYT' (the sequence of this
probe is antisense to nt 49-2 ofA) . The four cell lines show
a positive signal at -3 .2 kb.
(22) . Only the PCR products from clones bearing STPB
were cut by Sall into the anticipated fragments (Fig . 7, lanes
3 and 5) . All four PCR products were cut by Stul into frag-
ments of the expected size (lanes 6-9), indicating they are
derived from cDNA inserts with STPB . If the PCR prod-
ucts of each cell line are the same as the products from the
known cDNA clones, they should be digested in a similar
fashion. Consequently, PCR products derived from HeLa were
digested with Sall and compared with the undigested prod-
ucts (Fig. 8) . Bands 1 and 3 were not cut, while bands 2
and 4 were digested into the fragments of the expected size .
In addition, all four bands were digested with Stul, and the
correct fragments were produced (Figs . 7 and 8) . A similar
result was observed for the K-562 PCR products, as Salt cut
bands 1 and 3 (lane 5) while Stul cut all four bands (Fig .
Figure 4 .
￿
Schematic diagram of the six classes of MCP
cDNA clones obtained by bothcDNA cloning andPCR anal-
ysis of mRNA . Abbreviations are SP, signal peptide ; SCRs
short consensus repeats ; STP, three domains enriched in serines,
threonines, and prolines ; UK, area of unknown significance;
HY, hydrophobic transmembrane domain with anchor ; and
CYT, cytoplasmic tail . Clones designated byK were derived
from cell line K-562 ; HL, from HeLa ; and H2, from HEp-2 .
Isoform class denotes content of STP-rich areas using capital
letters, and denotes cytoplasmic tails by the number 1 or 2 .Figure 5.
￿
PCR products derived from RNA of five human cell lines.
The oligonucleotides used as primers were from SCR-4 and the 3' UT
region ofMCP (see Materials and Methods) . Lane 1, molecular weight
markers in nt; lanes 2-6, PCR products ofthe cell lines noted . Thebands
marked 1-4 in this and subsequent figures refer to the fourPCR products .
Figure 6.
￿
PCR products derived from MCP cDNAs compared with
PCR products derived from HeLa cell RNA. Lanes 1, 2, 5, and 6 are
the PCR products derived from plasmids with known MCP cDNA in-
serts . The protein domains contained within thesecDNAs are shown above
each lane . Lane 3 shows all fourPCR products together, and lane 4 shows
thePCR products derived fromHeLacellRNA. Lane 7, molecularweight
markers in nt . Abbreviations areas per Fig. 4. Primers are the sameas Fig. 5.
8, lane 7) . This same pattern ofenzyme digestion was found
for U-937, HEp-2, and HSB-2 cell lines (data not shown) .
Therefore, the PCR products amplified in the cell lines
are the same as known MCPRNA isoforms (Fig. 6) . Bands
1 and 3 represent mRNA species that contain STPC with
either CYTZ (band 3) or CYTZ (band 1), while bands 2 and
4 represent those that contain STPB and STPB with either
CYTZ (band 4) or CYTZ (band 2) .
Correlation ofProtein Phenotype tomRNA Isoforms.
￿
PCR,
Northern blot, and transfection analyses were undertaken to
determine ifthere was a correlation between themRNA spe-
cies and protein phenotype.
PCR Analysis .
￿
Total RNA, derived from cell lines and
from peripheral blood cells of individuals possessing the three
protein phenotypes, was examined by PCR. The identity of
the PCR products was verified by restriction enzyme anal-
ysis (data not shown) . The relative amounts ofbands 2 (with
STPB and CYTZ) and 4 (with STPB and CYTZ) were in-
creased in individuals expressing predominantly the larger
protein phenotype ofMCP (Fig. 9) . In contrast, the relative
amounts of bands 1 (without STPB and with CYTZ) and 3
(without STPB and with CYTZ) were increased in individ-
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Figure 7.
￿
Restriction enzyme analysis ofthePCR products. Thestarting
(uncut) PCR products were the same as those in Fig. 6 . Lanes 1 and 10,
molecular weight markers in nt ; lanes 2-5, Sall digests ofthePCR prod-
ucts derived from plasmids with the protein domains as noted . Lanes 6-9,
Stul digests of the same PCR products as in lanes 2-5. Primers are the
same as in Fig. 5 .
Figure 8.
￿
Restriction enzyme analysis ofHeU and K-562PCR prod-
ucts. The starting (uncut) PCR products are the same as those in Fig.
5. Lane 1, molecular weight markers in nt ; lanes 2 and 5, Sall digests;
lanes 3 and 6, uncut PCR products ; lanes 4and 7, Stul digests. Primers
are the same as in Fig. 5 .
uals expressing predominantly the lower protein phenotype,
and comparable quantities ofbands 1 and 3 vs . 2 and 4 were
present in individuals expressing equal quantities of the lower
and upper protein forms. Also, this same correlation was ob-Figure 9 .
￿
PCR analysis of total RNA derived fromPBMC . Lanes 1-3,
individuals with the upper (L>) protein phenotype; lanes 4 and S, from
equal (E) protein phenotypes ; and lane 6, from a lower (L) band predomi-
nant proteinphenotype. Lane 7, molecular weight markers in nt . Primers
are the same as in Fig . 5 .
served in the cell lines (Fig. 5); thus, mRNA of cell lines
expressing mostly the higher molecular weight protein pheno-
type (U-937, K-562, and HSB-2) produced predominantly
PCR bands 2 and 4; the lower molecular weight protein
phenotype (Hep-2), bands 1 and 3 ; and the equal protein
phenotype (HeLa), comparable quantities of bands 1 and 3
vs. 2 and 4 .
Northem Analysis.
￿
A Northern blot containing total RNA
from several cell lines was probed with two antisense oligo-
nucleotideprobesft 10) . One probe was antisenseto SCR-4,
while the other was antisense to all of STPB . A plasmid con-
taining both the SCR-4 and STPB was used as a positive
control . Two cell lines (U-937 and K-562) expressing pre-
dominantly the larger protein phenotype demonstrated com-
parable hybridization signals to both probes (Fig. 10) . How-
ever, a cell line (HeLa) expressing about equal quantities and
the other one (HEp-2) expressing primarily the lower pro-
tein form demonstrate a diminished signal to the probe to
STPB, as compared with the signal from SCR-4 . Therefore,
this Northern blot analysis supported the results obtained
by PCR and indicated that the presence or absence ofSTPB
determines the protein phenotype.
Transfection.
￿
CHO cells were transfected with thecDNAs
and the expressed proteins were precipitated and analyzed by
SDS-PAGE followed by autoradiography (Fig. 11) . Cells trans-
Figure 10 .
￿
Northern blots offour cell lines probed with antisense oli-
gonucleotides to SCRA and STPB. (A) 20 pg of total RNA from each
offour cell lines was probed with an antisense oligonucleotide to SCR-4 ;
(B) an equivalent blot probed with an antisense oligonucleotide to STPB .
Lane S ofA and B, same quantity of a plasmid containing both SCR-4
and STPB .
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Figure 11 .
￿
A comparison of MCP of transfectants and cells and cell
lines. SDS-PAGE (10% inducing) analysis ofMCP immtmoprecipitates
ofcDNA transfectants, PBMC, and two human cell lines. The transfec-
tants and cell lines were biosynthetically labeled with 36S-cysteine. Blood
mononuclear cells of an individual etptessing about equal quantities of
the two forms ofMCP were labeled with 1251 . Thecontrol is CHO cells
transfected with anMCP cloneinreverse orientation. HEp-2 is apredom-
inantly lower (L) band protein phenotype, while K-562 is a predominantly
upper (U) bandprotein phenotype. TransfectedMCP isoforms areidentified
on the basis of their STP regions and cytoplasmic tails (see Fig. 4) . The
bands in lanes 3-9 with M r of 46,000-48,000 represent intracellular
precursors of MCP .
fected with cDNAs containing STPB migrated with anM
of 45,000-55,000 (Fig . 11, lanes 3 and 4) . In contrast, MCP
expressed inCHO cells with STPB migrated with an Mr
of 55,000-65,000 (Fig. 11, lanes 7 and 8) . TheMr of the ex-
pressed proteins were similar to those of MCP of cell lines
(lanes 5 and 6) and ofPBMC (lanes 2 and 10) . The type of
cytoplasmic tail had no detectable effect on theMr . Thus,
the presence of STPB defines the larger protein phenotype
and its absence produces the lower protein phenotype. These
results are entirely consistent with the PCR and Northern
analyses.
The MCP cDNA containing STP"c was also expressed
and had anMr of 65,000-75,000 (Fig. 11, lane 9) . Such spe-
cies have not been detected on human peripheral blood cells
or cell lines (4, 6, 7, 18, 19) (Fig. 11, lanes 2, 5, 6, and 10) .
Therefore, these results are consistent with those derived from
Northern blots (Fig . 3) and PCR (Figs . 5 and 6), and indi-
cate that STPABC bearing mRNAs are rare in these cell
populations.
Organization oftheMCP Gene
￿
To determine how the iso-
forms arise, three genomic bacteriophage libraries were
screened and genomic fragments obtained that contained 14
exons and 13 introns of theMCP gene (Fig . 12) . These exons,
spread over a length of-43 kb, contained one area that did
not overlap. All exons and surrounding intronic areas were
sequenced . The exonic sequences matched those of MCP
cDNAs and PCR clones. All exon/intron boundaries con-
formed to the GT/AG consensus sequence rule (37) . ExonExon 4
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sizesranged from 36 to 1,985 nt, whilethe sizesofthe charac-
terized introns ranged from 127 nt to -13 kb.
The first exon encodes the 5' UT/signal peptide region.
The next five exons encode the four SCRs of MCP. SCR-1,
SCR3, and SCR-4 are encoded by a single exon, whileSCR-2
is encoded by two equally sized exons. Interestingly, this "split"
exon occurs after the second nt of glycine 34. This pattern
is identical to the split exons of other complement regula-
tory proteins (1). Exons 7, 8, and 9 encode the three STP-
rich areas. Since the 5' donor splice site ofexons7 and 8 occurs
afterthe first nt of the triplet codon, the addition or deletion
of these exons does not disrupt the reading frame. Interest-
ingly, exons 7 and 8 have an overall homology of -70%.
Moreover, there is extensive homology in the 3' acceptor and
5' donor introns ofboth of these exons (Fig. 13), indicating
that these exons arose by intragenic duplication.
Exon 10 encodes for a 13 amino acid stretch of unknown
significance. Exons 11 and 12 encode for the hydrophobic trans-
membrane domain and the basic amino acid anchor. Exon
13 encodes for the 93-nt segment CYT 1. If axon 13 is
present in a transcript, this nt sequence codes for a cytoplasmic
tail of 16 amino acids. Since this exon also codes for an in-
frame stop codon, the presence of exon 13 converts exon 14
into the 3' UT region of MCP. If exon 13 is not present,
then exon 14 encodes the cytoplasmic tail of 23 amino acids,
named CYT2, and the 3' UT region of MCP.
Fig. 14 illustrates how alternative splicing of the STP and
CYT axons produces the multiple isoforms of MCP
G`o ~e G\ay 5
K5-9
K5-22 MCP-ABC2
HL-27 MCP-BC1
HL-1 MCP-BC2
H2-14 MCP-C1
Figure 12.
￿
Structure ofthehumanMCPgene. Theexon
number and corresponding encoded protein domain are
shown above each exon. Exon and intron sizes are drawn
to scale. As depicted by the slashed horizontal lines in the
first line, the intron between axons 10 and 11 has not been
cloned. The second line shows an ECORI and BamH1 re-
striction map of the MCP gene. Five bacteriophageclones
(,- IV17, XM2, XMl, XIVl3, and XC1) contained all 14 exons.
Abbreviations of protein domains are as per Fig. 4.
1-6 7
Figure 13. Homology between
STPA and STPB and surrounding in-
tronic areas. The nt sequences of the
3' acceptor intron, exon, and 5' donor
intron ofexons 7and 8are shown. The
encoded amino acids of exons 7 and 8
are centeredunder the second nt ofeach
triplet codon. Homologous nt between
the two sequences are overlined. Spacing
ofthe 3' acceptor intron of exon 7 was
aligned to maximize homology.
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Figure 14.
￿
Multiple MCP cDNAs are generated by alternative splicing.
The top illustrates the clone, isoform class, axon number, and the protein
domains of MCP cDNAs. Abbreviations are as per Fig. 4.Discussion
An unusual aspect of MCP is the variable expression of
two relatively broad protein species (2, 3, 6). The goal of
the present investigation was to determine the molecular basis
of this phenotypic observation. The approach taken was to
identify and characterize additional cDNA clones. As this
was progressing, the organization of the MCP gene was also
being determined. Six unique mRNA species were charac-
terized. Each mRNA encoded for an identical 5' UT region,
signal peptide, four SCRs, transmembrane domain, and basic
amino acid anchor. Due to variable splicing, the cDNAs
differed in the length of the STP-rich area and in the type
of cytoplasmic tail. Alternative splicing produces three different
STP-rich regions and two distinct cytoplasmic tails. The al-
ternative splicing event that gives rise to the two tails occurs
with each of the splicing events involving the STP exons;
that is, each variation in the STP region was found with
each tail.
To relate these molecular observations to those previously
made at the protein level, three types ofmRNA analyses were
performed. PCR analysis, using primers encompassing the
area ofvariability within the mRNA, demonstrated that vari-
able quantities of four primary MCP mRNA species were
expressed in cell lines and in peripheral blood cells. Two
of these mRNA species possessed and two lacked STPB.
Northern blots indicated that the relative predominance of
isoforms with STPB correlated with the higher molecular
weight protein phenotype, while the predominance of iso-
forms without STPB correlated with the lower molecular
weight protein phenotype. This finding was supported by
transfection analysis, as cDNAs with STPB produced pro-
teins with an Mof the larger species, while those without
STPB had an Msimilar to the smaller protein species. Taken
together, these data establish that a cell's MCP phenotype
depends on the content o£ the STP area of the predominant
mRNA isoforms.
A role for STP-rich regions (and therefore O-glycosylation)
in defining the two major forms of MCP was in part antici-
pated, since the larger species possesses more sialic acid than
the smaller one (19). Although STPB is only 15 amino acids
long, 11 residues are S, T, or P. Thus, the attachment of
0-linked sugars could account for the molecular weight differ-
ence between the protein species. Further, the broadness of
the forms of MCP is largely accounted for by post-translational
modifications, at least in part due to the addition of carbohy-
drate (19). It is likely that variability in the number of O-linked
sugars attached to the STP-rich areas explains this heteroge-
neity. That MCP transfected into CHO cells produced ma-
ture proteins exhibiting broad bands on gels supports this
suggestion. The seven amino acid differencebetween the two
tails may also account for some of the variability in size, al-
though transfectants identical except for their cytoplasmic
tails were not separable on SDS-PAGE.
The transfectants bearing the different forms ofMCP will
be useful in future studies. For example, up to four forms
of MCP are expressed on a single cell. The biologic significance
of such diversity for a regulatory membrane protein is un-
known and would be interesting to examine. Also, the role
of STRrich domains adjacent to a transmembrane domain
is not well understood. Several receptor and membrane-bound
glycoproteins, such as the low density lipoprotein receptor
(38), the IL-2 receptor (39-41), and another RCA protein,
DAF (42, 43), have STP-rich areas immediately adjacent to
their transmembrane domains. While the function of the
STP domain is unknown, some evidence suggests that O-gly-
cosylation may protect the protein from proteolysis (44, 45) .
Alternative splicing of the STP-rich exons in these genes has
not been described,,and MCP is unique in this regard. In-
terestingly, the leukocyte common antigen family, whose
structural gene is also located at 1832 (46), resembles MCP
in that variable splicing among STP-rich exons is used to pro-
duce multiple cDNA species. In this gene, though, alterna-
tive splicing may be cell specific, and this region, located at
the NH2 terminus of the protein, is postulated to be a lectin
binding domain. The variation in the STP region of MCP
isoforms is a model system to analyze the function of such
domains in mammalian proteins.
Finally, the biologic significance of the two cytoplasmic
tails will be ofinterest to evaluate. Approximately equal quan-
tities ofMCP forms bearing each tail are expressed on human
cells. Previous studies demonstrated that the processing of
two precursor forms of MCP varied fourfold (19). Prelimi-
nary studies indicate that the cytoplasmic tail determines this
difference, and further analysis ofthis observation should pro-
vide insights into the signals required for the processing and
compartmentalization of mammalian precursor proteins.
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